{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:40:18Z","timestamp":1777462818958,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer New York","isbn-type":[{"value":"9781493978151","type":"print"},{"value":"9781493978168","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7816-8_10","type":"book-chapter","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T13:06:41Z","timestamp":1528549601000},"page":"147-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Purification and Fibrillation of Recombinant Human Amyloid-\u03b2, Prion Protein, and Tau Under Native Conditions"],"prefix":"10.1007","author":[{"given":"Alexander","family":"Sandberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","volume":"130","author":"JD Sipe","year":"2000","unstructured":"Sipe JD, Cohen AS (2000) Review: history of the amyloid fibril. J Struct Biol 130:88\u201398","journal-title":"J Struct Biol"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","volume":"23","author":"JD Sipe","year":"2016","unstructured":"Sipe JD, Benson MD, Buxbaum JN et al (2016) Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature guidelines. Amyloid 23:209\u2013213","journal-title":"Amyloid"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.412251","volume":"198","author":"K Itakura","year":"1977","unstructured":"Itakura K, Hirose T, Crea R et al (1977) Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198:1056\u20131063","journal-title":"Science"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H III (2010) Alzheimer\u2019s disease and the amyloid-beta peptide. J Alzheimers Dis 19:311\u2013323","journal-title":"J Alzheimers Dis"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1742-4658.2008.06862.x","volume":"276","author":"DM Walsh","year":"2009","unstructured":"Walsh DM, Thulin E, Minogue AM et al (2009) A facile method for expression and purification of the Alzheimer\u2019s disease-associated amyloid beta-peptide. FEBS J 276:1266\u20131281","journal-title":"FEBS J"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/1521654032000114348","volume":"55","author":"M Tolnay","year":"2003","unstructured":"Tolnay M, Probst A (2003) The neuropathological spectrum of neurodegenerative tauopathies. IUBMB Life 55:299\u2013305","journal-title":"IUBMB Life"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"ftv087","DOI":"10.1093\/femspd\/ftv087","volume":"73","author":"MD Zabel","year":"2015","unstructured":"Zabel MD, Reid C (2015) A brief history of prions. Pathog Dis 73:ftv087","journal-title":"Pathog Dis"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0014-5793(97)01330-6","volume":"417","author":"R Zahn","year":"1997","unstructured":"Zahn R, von Schroetter C, Wuthrich K (1997) Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett 417:400\u2013404","journal-title":"FEBS Lett"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1472-6750-8-82","volume":"8","author":"B Macao","year":"2008","unstructured":"Macao B, Hoyer W, Sandberg A et al (2008) Recombinant amyloid beta-peptide production by coexpression with an affibody ligand. BMC Biotechnol 8:82","journal-title":"BMC Biotechnol"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pep.2009.02.009","volume":"66","author":"K Garai","year":"2009","unstructured":"Garai K, Crick SL, Mustafi SM et al (2009) Expression and purification of amyloid-beta peptides from Escherichia coli. Protein Expr Purif 66:107\u2013112","journal-title":"Protein Expr Purif"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nsmb.2991","volume":"22","author":"Y Xiao","year":"2015","unstructured":"Xiao Y, Ma B, McElheny D et al (2015) Abeta(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer\u2019s disease. Nat Struct Mol Biol 22:499\u2013505","journal-title":"Nat Struct Mol Biol"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.1021\/jacs.6b05129","volume":"138","author":"MT Colvin","year":"2016","unstructured":"Colvin MT, Silvers R, Ni QZ et al (2016) Atomic resolution structure of monomorphic Abeta42 amyloid fibrils. J Am Chem Soc 138:9663\u20139674","journal-title":"J Am Chem Soc"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"E4976","DOI":"10.1073\/pnas.1600749113","volume":"113","author":"MA W\u00e4lti","year":"2016","unstructured":"W\u00e4lti MA, Ravotti F, Arai H et al (2016) Atomic-resolution structure of a disease-relevant Abeta(1-42) amyloid fibril. Proc Natl Acad Sci U S A 113:E4976\u2013E4984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"11858","DOI":"10.1073\/pnas.1503455112","volume":"112","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Rohou A, Lasker K et al (2015) Peptide dimer structure in an Abeta(1-42) fibril visualized with cryo-EM. Proc Natl Acad Sci U S A 112:11858\u201311863","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1074\/jbc.M114.589309","volume":"290","author":"B Falcon","year":"2015","unstructured":"Falcon B, Cavallini A, Angers R et al (2015) Conformation determines the seeding potencies of native and recombinant Tau aggregates. J Biol Chem 290:1049\u20131065","journal-title":"J Biol Chem"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0197-0186(01)00137-1","volume":"41","author":"A Corsaro","year":"2002","unstructured":"Corsaro A, Thellung S, Russo C et al (2002) Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein. Neurochem Int 41:55\u201363","journal-title":"Neurochem Int"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1021\/bi9923353","volume":"39","author":"IV Baskakov","year":"2000","unstructured":"Baskakov IV, Aagaard C, Mehlhorn I et al (2000) Self-assembly of recombinant prion protein of 106 residues. Biochemistry 39:2792\u20132804","journal-title":"Biochemistry"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"21140","DOI":"10.1074\/jbc.M111402200","volume":"277","author":"IV Baskakov","year":"2002","unstructured":"Baskakov IV, Legname G, Baldwin MA et al (2002) Pathway complexity of prion protein assembly into amyloid. J Biol Chem 277:21140\u201321148","journal-title":"J Biol Chem"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1126\/science.283.5409.1935","volume":"283","author":"GS Jackson","year":"1999","unstructured":"Jackson GS, Hosszu LL, Power A et al (1999) Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283:1935\u20131937","journal-title":"Science"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jmb.2004.11.068","volume":"346","author":"OV Bocharova","year":"2005","unstructured":"Bocharova OV, Breydo L, Parfenov AS et al (2005) In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J Mol Biol 346:645\u2013659","journal-title":"J Mol Biol"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12915-017-0375-5","volume":"15","author":"MA Wulf","year":"2017","unstructured":"Wulf MA, Senatore A, Aguzzi A (2017) The biological function of the cellular prion protein: an update. BMC Biol 15:34","journal-title":"BMC Biol"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4161\/pri.3.4.10112","volume":"3","author":"K Almstedt","year":"2009","unstructured":"Almstedt K, Nystr\u00f6m S, Nilsson KP et al (2009) Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates. Prion 3:224\u2013235","journal-title":"Prion"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"25975","DOI":"10.1074\/jbc.M112.372136","volume":"287","author":"S Nystr\u00f6m","year":"2012","unstructured":"Nystr\u00f6m S, Mishra R, Hornemann S et al (2012) Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway. J Biol Chem 287:25975\u201325984","journal-title":"J Biol Chem"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"10101","DOI":"10.1038\/srep10101","volume":"5","author":"S Nystrom","year":"2015","unstructured":"Nystrom S, Hammarstrom P (2015) Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions. Sci Rep 5:10101","journal-title":"Sci Rep"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"27236","DOI":"10.1074\/jbc.M111.248963","volume":"286","author":"Y Furukawa","year":"2011","unstructured":"Furukawa Y, Kaneko K, Nukina N (2011) Tau protein assembles into isoform- and disulfide-dependent polymorphic fibrils with distinct structural properties. J Biol Chem 286:27236\u201327246","journal-title":"J Biol Chem"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1021\/bi400866w","volume":"52","author":"OA Morozova","year":"2013","unstructured":"Morozova OA, March ZM, Robinson AS et al (2013) Conformational features of tau fibrils from Alzheimer\u2019s disease brain are faithfully propagated by unmodified recombinant protein. Biochemistry 52:6960\u20136967","journal-title":"Biochemistry"}],"container-title":["Methods in Molecular Biology","Amyloid Proteins"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7816-8_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T13:07:44Z","timestamp":1528549664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7816-8_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493978151","9781493978168"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7816-8_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}